Zolgensma (onasemnogene abeparvovec-xioi) and Spinraza (nusinersen sodium) are both treatments for people with spinal muscular atrophy (SMA). There are a number of key differences between the two treatments, including:
Which patients with SMA they are approved for use in
How often they are administered
The type of treatments they are
How they work
How well they work